Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mechanical and Electrical Dyssynchrony During His-Bundle Pacing Versus His-Bundle Area Right Ventricular Pacing

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04697797
Recruitment Status : Recruiting
First Posted : January 6, 2021
Last Update Posted : January 27, 2022
Sponsor:
Information provided by (Responsible Party):
Medical University of Lodz

Brief Summary:
The aim of this study is to evaluate mechanical and electrical cardiac dyssynchrony in patients with pacemakers and the right ventricular electrode implanted in His Bundle area.

Condition or disease Intervention/treatment
Bradyarrhythmia Other: Device Programming

Detailed Description:

Permanent His Bundle Pacing (HBP) is a well-known method of cardiac pacing which is increasingly used in everyday practice. After lead implantation in His Bundle area (HBA) capture of various tissues can be achieved: A. right ventricular myocardium near to HBP; B. cardiac conduction system selectively or nonselectively (with concomitant regional myocardium activation). The different excitability and refractory periods decide which tissue, myocardium or/and the conduction system is effectively paced. A lot of clinical trials revealed the advantage of HBP over apical ventricular pacing (AVP). HBP improves clinical (NYHA, quality of life, hospitalization rate) and echocardiographic (left ventricular dimension and ejection fraction) indicators of heart failure.

We are going to compare mechanical and electrical synchrony during the various type of myocardium activation: HBP (nsHBP or sHBP), RV pacing near HBA and native heart rhythm (if possible) in each patient recruited to the study. Adequate pacemaker programming will allow achieving different activations as shown above. The mechanical synchrony will be estimated by transthoracic echocardiography and the electrical one by the detailed analysis of ECG.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Mechanical and Electrical Dyssynchrony During His-Bundle Pacing (Selective and Non-selective) Versus His-Bundle Area Right Ventricular Pacing
Actual Study Start Date : December 14, 2020
Estimated Primary Completion Date : June 30, 2022
Estimated Study Completion Date : December 31, 2022

Intervention Details:
  • Other: Device Programming
    Intervention includes (1) pacemaker reprogramming (2) echocardiographic parameters acquisition (3) ECG recording
    Other Names:
    • Echocardiography
    • ECG


Primary Outcome Measures :
  1. Interventricular mechanical delay [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]
    InterVentricular Mechanical Dyssynchrony Parameter 1

  2. Interventricular mechanical delay [ Time Frame: Long term: 12-15 months after pacemaker implantation ]
    InterVentricular Mechanical Dyssynchrony Parameter 1

  3. Free-wall-LV-to-RV-delay [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]
    InterVentricular Mechanical Dyssynchrony Parameter 2

  4. Free-wall-LV-to-RV-delay [ Time Frame: Long term: 12-15 months after pacemaker implantation ]
    InterVentricular Mechanical Dyssynchrony Parameter 2

  5. Septal-to-posterior wall motion delay [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]
    IntraVentricular Mechanical Dyssynchrony Parameter 1

  6. Septal-to-posterior wall motion delay [ Time Frame: Long term: 12-15 months after pacemaker implantation ]
    IntraVentricular Mechanical Dyssynchrony Parameter 1

  7. Opposing wall motion delay [ Time Frame: Long term: 12-15 months after pacemaker implantation ]
    IntraVentricular Mechanical Dyssynchrony Parameter 2

  8. Opposing wall motion delay [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]
    IntraVentricular Mechanical Dyssynchrony Parameter 2

  9. systolic dyssynchrony index [ Time Frame: Long term: 12-15 months after pacemaker implantation ]
    Ventricular Mechanical Dyssynchrony Parameter 1

  10. systolic dyssynchrony index [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]
    Ventricular Mechanical Dyssynchrony Parameter 1

  11. QRS duration [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]
    Electrical dyssynchrony Parameter

  12. QRS duration [ Time Frame: Long term: 12-15 months after pacemaker implantation ]
    Electrical dyssynchrony Parameter


Secondary Outcome Measures :
  1. Radial strain [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]
    Additional Ventricular Mechanical Dyssynchrony Parameter 1

  2. Radial strain [ Time Frame: Long term: 12-15 months after pacemaker implantation ]
    Additional Ventricular Mechanical Dyssynchrony Parameter 1

  3. Left Ventricular Ejection Fraction [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]
    Global left ventricle function parameter

  4. Left Ventricular Ejection Fraction [ Time Frame: Long term: 12-15 months after pacemaker implantation ]
    Global left ventricle function parameter

  5. Global longitudinal strain [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]
    Global left ventricle function parameter 2

  6. Global longitudinal strain [ Time Frame: Long term: 12-15 months after pacemaker implantation ]
    Global left ventricle function parameter 2

  7. Left ventricular output track velocity-time integral [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]
    Global left ventricle function parameter 3

  8. Left ventricular output track velocity-time integral [ Time Frame: Long term: 12-15 months after pacemaker implantation ]
    Global left ventricle function parameter 3

  9. Diastolic Filling Time [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]
    Atrioventricular Dyssynchrony Parameter

  10. Diastolic Filling Time [ Time Frame: Long term: 12-15 months after pacemaker implantation ]
    Atrioventricular Dyssynchrony Parameter



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with bradyarrhythmia and indications for de novo permanent pacemaker implantation. The decision for pacing lead placement in His Bundle is left for physician discretion. Patients after pacemaker system implantation with His Bundle successfully pacing are to be asked to participate in the study. After having written informed consent obtained patients are to be scheduled for ventricular synchrony evaluation with ECHO and ECG after 3-6 months after implant (mid-term) and after 12 months (long-term).
Criteria

Inclusion Criteria:

  • all adult patients after implantation of pacemaker system with pacing lead successfully captured His Bundle (selectively or/and nonselectively)

Exclusion Criteria:

  • not willing or incapable to give written informed consent;
  • previous implanted cardiac electronic device (pacemaker, implantable cardioverter-defibrillator, cardiac resynchronization therapy device)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04697797


Contacts
Layout table for location contacts
Contact: Krzysztof A Kaczmarek, MD, PhD +48 42 201 43 60 krzysztof.kaczmarek@umed.lodz.pl

Locations
Layout table for location information
Poland
Department of Electrocardiology Medical University of Lodz Recruiting
Lodz, Poland, 93-216
Contact: Krzysztof A Kaczmarek, MD, PhD    +48 42 201 43 60    krzysztof.kaczmarek@umed.lodz.pl   
Sponsors and Collaborators
Medical University of Lodz
Layout table for additonal information
Responsible Party: Medical University of Lodz
ClinicalTrials.gov Identifier: NCT04697797    
Other Study ID Numbers: RNN/147/20/KE
First Posted: January 6, 2021    Key Record Dates
Last Update Posted: January 27, 2022
Last Verified: January 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Medical University of Lodz:
His Bundle Pacing
Dyssynchrony
Echocardiography
ECG
Additional relevant MeSH terms:
Layout table for MeSH terms
Bradycardia
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes